Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Share-based Compensation: 2024-2025

Historic Share-based Compensation for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $3.1 million.

  • Pyxis Oncology's Share-based Compensation rose 3.09% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year change of. This contributed to the annual value of $12.9 million for FY2024, which is 23.61% down from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Share-based Compensation is $3.1 million, which was up 1.92% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Share-based Compensation registered a high of $4.3 million during Q1 2024, and its lowest value of $2.8 million during Q4 2024.
  • In the last 2 years, Pyxis Oncology's Share-based Compensation had a median value of $3.0 million in 2025 and averaged $3.2 million.
  • The largest annual percentage gain for Pyxis Oncology's Share-based Compensation in the last 5 years was 5.02% (2025), contrasted with its biggest fall of 15.95% (2025).
  • Pyxis Oncology's Share-based Compensation (Quarterly) stood at $2.8 million in 2024, then rose by 3.09% to $3.1 million in 2025.
  • Its Share-based Compensation was $3.1 million in Q3 2025, compared to $3.0 million in Q2 2025 and $3.6 million in Q1 2025.